Cargando…

Surgeon workload and survival from breast cancer

The formation of multidisciplinary breast teams across the UK is intended to concentrate the assessment and treatment of breast cancer into the hands of high volume specialists. We undertook a retrospective population-based study in order to determine the trends in surgeon breast cancer workload in...

Descripción completa

Detalles Bibliográficos
Autores principales: Mikeljevic, J Stefoski, Haward, R A, Johnston, C, Sainsbury, R, Forman, D
Formato: Texto
Lenguaje:English
Publicado: Nature Publishing Group 2003
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2394379/
https://www.ncbi.nlm.nih.gov/pubmed/12888817
http://dx.doi.org/10.1038/sj.bjc.6601148
_version_ 1782155402099556352
author Mikeljevic, J Stefoski
Haward, R A
Johnston, C
Sainsbury, R
Forman, D
author_facet Mikeljevic, J Stefoski
Haward, R A
Johnston, C
Sainsbury, R
Forman, D
author_sort Mikeljevic, J Stefoski
collection PubMed
description The formation of multidisciplinary breast teams across the UK is intended to concentrate the assessment and treatment of breast cancer into the hands of high volume specialists. We undertook a retrospective population-based study in order to determine the trends in surgeon breast cancer workload in Yorkshire, UK, and to investigate whether patients treated by low-workload surgeons had poorer survival. Of 11 329 female breast cancer patients diagnosed in 1989–1994 in Yorkshire, 6% were managed by surgeons with a mean annual workload of less than 10 new patients, while surgeons with workloads of 10–29, 30–49 and >50 treated 21, 21 and 52%, respectively. Over the study period, increasing number of patients were managed by surgeons with higher workloads. Patients treated by low-workload surgeons had poorer survival. Five-year survival was 60% in the lowest workload category compared to 68% in the highest category. The relative risk of death was increased by 15% (RR=1.15, 95% CI 1.03–1.28) and by 10% (RR=1.10, 95% CI 1.02–1.18) for patients managed by surgeons with workloads <10 and 10–29 cases per annum in comparison to patients managed by surgeons with workloads of >50. The results of this study suggest increasing site specialisation in breast cancer among general surgeons. It also provides further evidence that the management of patients by surgeons with low workloads decreases overall survival.
format Text
id pubmed-2394379
institution National Center for Biotechnology Information
language English
publishDate 2003
publisher Nature Publishing Group
record_format MEDLINE/PubMed
spelling pubmed-23943792009-09-10 Surgeon workload and survival from breast cancer Mikeljevic, J Stefoski Haward, R A Johnston, C Sainsbury, R Forman, D Br J Cancer Clinical The formation of multidisciplinary breast teams across the UK is intended to concentrate the assessment and treatment of breast cancer into the hands of high volume specialists. We undertook a retrospective population-based study in order to determine the trends in surgeon breast cancer workload in Yorkshire, UK, and to investigate whether patients treated by low-workload surgeons had poorer survival. Of 11 329 female breast cancer patients diagnosed in 1989–1994 in Yorkshire, 6% were managed by surgeons with a mean annual workload of less than 10 new patients, while surgeons with workloads of 10–29, 30–49 and >50 treated 21, 21 and 52%, respectively. Over the study period, increasing number of patients were managed by surgeons with higher workloads. Patients treated by low-workload surgeons had poorer survival. Five-year survival was 60% in the lowest workload category compared to 68% in the highest category. The relative risk of death was increased by 15% (RR=1.15, 95% CI 1.03–1.28) and by 10% (RR=1.10, 95% CI 1.02–1.18) for patients managed by surgeons with workloads <10 and 10–29 cases per annum in comparison to patients managed by surgeons with workloads of >50. The results of this study suggest increasing site specialisation in breast cancer among general surgeons. It also provides further evidence that the management of patients by surgeons with low workloads decreases overall survival. Nature Publishing Group 2003-08-04 2003-07-29 /pmc/articles/PMC2394379/ /pubmed/12888817 http://dx.doi.org/10.1038/sj.bjc.6601148 Text en Copyright © 2003 Cancer Research UK https://creativecommons.org/licenses/by/4.0/This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made.The images or other third party material in this article are included in the article’s Creative Commons license, unless indicated otherwise in a credit line to the material.If material is not included in the article’s Creative Commons license and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this license, visit https://creativecommons.org/licenses/by/4.0/.
spellingShingle Clinical
Mikeljevic, J Stefoski
Haward, R A
Johnston, C
Sainsbury, R
Forman, D
Surgeon workload and survival from breast cancer
title Surgeon workload and survival from breast cancer
title_full Surgeon workload and survival from breast cancer
title_fullStr Surgeon workload and survival from breast cancer
title_full_unstemmed Surgeon workload and survival from breast cancer
title_short Surgeon workload and survival from breast cancer
title_sort surgeon workload and survival from breast cancer
topic Clinical
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2394379/
https://www.ncbi.nlm.nih.gov/pubmed/12888817
http://dx.doi.org/10.1038/sj.bjc.6601148
work_keys_str_mv AT mikeljevicjstefoski surgeonworkloadandsurvivalfrombreastcancer
AT hawardra surgeonworkloadandsurvivalfrombreastcancer
AT johnstonc surgeonworkloadandsurvivalfrombreastcancer
AT sainsburyr surgeonworkloadandsurvivalfrombreastcancer
AT formand surgeonworkloadandsurvivalfrombreastcancer